Skip to content

Clinical study on the treatment of chronic obstructive pulmonary disease group D in stable stage with integrated traditional Chinese and Western Medicine

Clinical study on the treatment of chronic obstructive pulmonary disease group D in stable stage with integrated traditional Chinese and Western Medicine

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004968
Enrollment
Unknown
Registered
2021-06-21
Start date
2021-10-11
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-75 years; 2. Meet the diagnostic criteria for stable chronic obstructive pulmonary disease in Western medicine; 3. Meet the diagnostic criteria of TCM syndrome of yang deficiency and blood stasis and phlegm turbidity in the lung; 4. Acute exacerbation >= 2 times or >= 1 time leading to hospitalization in 1 year; 5. mMRC grade >= 2; 6. Exclude other lung diseases and lung diseases caused by other systemic diseases; 7. Agree to participate in clinical observation and be able to receive treatment and various examinations, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Asymptomatic or only pulmonary function test FEV1/FVC<0.70; 2. Suffering from severe cardiovascular disease, central nervous system disease, liver and kidney insufficiency, history of gastrointestinal bleeding, severe diabetes, malignant tumor and other diseases; 3. Patients with anxiety, depression and other mental illnesses; 4. Allergic constitution and allergic to the test drug; 5. Those who cannot take the medicine on time and are not expected to complete the 6-month treatment and follow-up; 6. Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
TCM syndrome quantification integral;

Countries

China

Contacts

Public ContactLu Yun
luyun999@126.com+86 18980880121

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026